Biogen

$266.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.73 (+0.27%) As of 5:16 PM UTC today

Why Robinhood?

You can buy or sell Biogen and other stocks, options, and ETFs commission-free!

About BIIB

Biogen Inc. Common Stock, also called Biogen, is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases.

CEO
Michel Vounatsos
Employees
9,100
Headquarters
Cambridge, Massachusetts
Founded
1978
Market Cap
41.11B
Price-Earnings Ratio
10.60
Dividend Yield
—
Average Volume
966.39K
High Today
$270.27
Low Today
$264.63
Open Price
$267.39
Volume
292.31K
52 Week High
$363.92
52 Week Low
$223.25

BIIB News

BenzingaApr 8

Biogen, Bio-Thera Ink Licensing Agreement For Development Of Actemra-Based Biosimilar For Rheumatoid Arthritis

Biogen Inc (NASDAQ: BIIB) and Bio-Thera Solutions Ltd have entered into a commercialization and license agreement to develop, manufacture, and commercialize BAT

BIIB Earnings

$0.00
$3.42
$6.84
$10.26
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available Apr 22, Pre-Market

You May Also Like

DOO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure